Doctor and writer Atul Gawand will head up a company to find solutions for the healthcare the founding companies’ give their employees.
health care
Posted inBusiness, Local & State, Maine Cannabis Report, News
Maine’s highest court rules employers can’t be forced to cover cost of medical marijuana
In a narrow ruling, justices say federal law trumps state law in a case involving medical treatment for an injured paper worker.
advertisement
Posted inNation & World
Suicide rates up in nearly every state, according to new CDC report
Suicide is rarely caused by any single factor, health officials said, but information from coroners’ reports suggest many of the deaths followed relationship problems, substance use and financial crises.
Posted inBusiness, Local & State, News
Rate hikes sought by Maine’s ACA insurers come in lower than expected for 2019
The proposed increases for individual health plans average just over 9 percent, and they will be reduced further if a state-run reinsurance program is revived.
Posted inLocal & State, Maine Crime, News
Fate of Rockland man who allegedly talked about school shooting rests with doctors
Brandon Luzzi is being held at Pen Bay Medical Center while clinicians determine whether he is well enough mentally to go home or needs treatment.
Posted inMaine Voices, Op-Eds, Opinion
Maine Voices: Let’s hear positions on health care from a wide range of candidates
Our nonprofit group tried surveying some and got a 44 percent response on the top issue for voters in the state.
Posted inBusiness, Local & State, News
Mercy Hospital receives $2.8 million donation that honors ‘Dr. Harry’
The gift comes from the family of the late Dr. Harry Davis, Mercy’s first chief of pediatrics.
Posted inOp-Eds, Opinion
The Maine Millennial: As Sen. McCain’s presence intersects with my life, I see our similarities
We may disagree on policy issues, but I suspect he would understand I love our country just as much as he does.
Posted inNation & World, News
FDA approves long-acting drug to prevent migraines
Aimovig, taken in a monthly shot, is the first in a new class of migraine drugs to win approval. It will cost $6,900 a year, without insurance.
Posted inBusiness
FDA names drugmakers accused of blocking cheaper generics
Regulators say some drugmakers use ‘gaming tactics’ to block cheaper copycat versions.